{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:10:54Z","timestamp":1779135054268,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,18]]},"DOI":"10.7759\/cureus.109134","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:26:07Z","timestamp":1779132367000},"source":"Crossref","is-referenced-by-count":0,"title":["Monoclonal Gammopathy as a Potential Cause of Pure Red Cell Aplasia: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Pone","family":"De Weerdt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Van Riet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Fostier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2023.06.009","article-title":"Pure red cell aplasia: the second hundred years","volume":"366","author":"Means RT Jr","year":"2023","unstructured":"Means RT Jr. Pure red cell aplasia: the second hundred years. Am J Med Sci. 2023, 366:160-6. 10.1016\/j.amjms.2023.06.009","journal-title":"Am J Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/JBR.0000000000000151","article-title":"Acquired pure red cell aplasia: unraveling the immune pathogenesis","volume":"6","author":"Liu M","year":"2023","unstructured":"Liu M, Zhang T, Dong X, Wang H. Acquired pure red cell aplasia: unraveling the immune pathogenesis. J Bio-X Res. 2023, 6:138-48. 10.1097\/JBR.0000000000000151","journal-title":"J Bio-X Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14012","article-title":"Monoclonal gammopathy-associated pure red cell aplasia","volume":"173","author":"Korde N","year":"2016","unstructured":"Korde N, Zhang Y, Loeliger K, et al.. Monoclonal gammopathy-associated pure red cell aplasia. Br J Haematol. 2016, 173:876-83. 10.1111\/bjh.14012","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06565-x","article-title":"Anti-plasma cell therapy in patients with monoclonal gammopathy-associated refractory pure red cell aplasia: a report of three cases and literature review","volume":"104","author":"Huang L","year":"2025","unstructured":"Huang L, Li M, Niu T, Chang H. Anti-plasma cell therapy in patients with monoclonal gammopathy-associated refractory pure red cell aplasia: a report of three cases and literature review. Ann Hematol. 2025, 104:4837-41. 10.1007\/s00277-025-06565-x","journal-title":"Ann Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2024.02.013","article-title":"Monoclonal gammopathy of anemic significance? Resolution of pure red cell aplasia with daratumumab-based therapy","volume":"137","author":"Khan O","year":"2024","unstructured":"Khan O, Prakash S, Chung A, Wong SW, Kennedy VE. Monoclonal gammopathy of anemic significance? Resolution of pure red cell aplasia with daratumumab-based therapy. Am J Med. 2024, 137:589-91. 10.1016\/j.amjmed.2024.02.013","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.964","article-title":"Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone","volume":"5","author":"Michel CS","year":"2024","unstructured":"Michel CS, Fehr EM, Nolte H, et al.. Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone. EJHaem. 2024, 5:838-41. 10.1002\/jha2.964","journal-title":"EJHaem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2021.102573","article-title":"Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone","volume":"89","author":"Zhang L","year":"2021","unstructured":"Zhang L, Chen N, Xu Z, et al.. Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone. Blood Cells Mol Dis. 2021, 89:102573. 10.1016\/j.bcmd.2021.102573","journal-title":"Blood Cells Mol Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1574007","article-title":"Acquired red cell aplasia associated with monoclonal gammopathy of undetermined significance","volume":"60","author":"Eziokwu AS","year":"2019","unstructured":"Eziokwu AS, Silver B, Samaras C. Acquired red cell aplasia associated with monoclonal gammopathy of undetermined significance. Leuk Lymphoma. 2019, 60:2337-9. 10.1080\/10428194.2019.1574007","journal-title":"Leuk Lymphoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2016.160730","article-title":"Pure red cell aplasia associated with monoclonal gammopathy of undetermined significance and literature review","volume":"63","author":"Gu H","year":"2017","unstructured":"Gu H, Lee WI, Jeon Y, Kang SY, Kim MH, Park TS. Pure red cell aplasia associated with monoclonal gammopathy of undetermined significance and literature review. Clin Lab. 2017, 63:373-8. 10.7754\/Clin.Lab.2016.160730","journal-title":"Clin Lab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:538-48. 10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.175810","article-title":"Rational management approach to pure red cell aplasia","volume":"103","author":"Balasubramanian SK","year":"2018","unstructured":"Balasubramanian SK, Sadaps M, Thota S, et al.. Rational management approach to pure red cell aplasia. Haematologica. 2018, 103:221-30. 10.3324\/haematol.2017.175810","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010898","article-title":"How I manage acquired pure red cell aplasia in adults","volume":"137","author":"Gurnari C","year":"2021","unstructured":"Gurnari C, Maciejewski JP. How I manage acquired pure red cell aplasia in adults. Blood. 2021, 137:2001-9. 10.1182\/blood.2021010898","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V59.1.114.114","article-title":"Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children","volume":"59","author":"Dessypris EN","year":"1982","unstructured":"Dessypris EN, Krantz SB, Roloff JS, Lukens JN. Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. Blood. 1982, 59:114-23.","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.58.2.493","article-title":"Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei","volume":"58","author":"Krantz SB","year":"1967","unstructured":"Krantz SB, Kao V. Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proc Natl Acad Sci U S A. 1967, 58:493-500. 10.1073\/pnas.58.2.493","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand JP","year":"2018","unstructured":"Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood. 2018, 132:1478-85. 10.1182\/blood-2018-04-839480","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010587","article-title":"Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis","volume":"7","author":"Lobbes H","year":"2023","unstructured":"Lobbes H, Lega JC, Le Guenno G, Ruivard M, Mainbourg S. Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis. Blood Adv. 2023, 7:6451-65. 10.1182\/bloodadvances.2023010587","journal-title":"Blood Adv"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2540016","article-title":"Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory\/relapsed pure red cell aplasia: a prospective clinical study","volume":"57","author":"Zhang L","year":"2025","unstructured":"Zhang L, Shen Y, Li R, et al.. Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory\/relapsed pure red cell aplasia: a prospective clinical study. Ann Med. 2025, 57:2540016. 10.1080\/07853890.2025.2540016","journal-title":"Ann Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01315-8","article-title":"Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party","volume":"15","author":"Gagelmann N","year":"2025","unstructured":"Gagelmann N, Witte M, Peczynski C, et al.. Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party. Blood Cancer J. 2025, 15:106. 10.1038\/s41408-025-01315-8","journal-title":"Blood Cancer J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485717-monoclonal-gammopathy-as-a-potential-cause-of-pure-red-cell-aplasia-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:26:08Z","timestamp":1779132368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485717-monoclonal-gammopathy-as-a-potential-cause-of-pure-red-cell-aplasia-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.109134","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}